Adma Biologics reported $3.81B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Adma Biologics USD 3.49B 853M Sep/2025
Alnylam Pharmaceuticals USD 39.74B 12.8B Feb/2026
BioCryst Pharmaceuticals USD 1.23B 115M Dec/2023
Minerva Neurosciences USD 43M 5M Dec/2023
Novavax USD 684M 43M Sep/2023
Omeros USD 184M 158M Sep/2023
Takeda JPY 7.64T 774.9B Dec/2025